Overview

• A recent QM Estudios de Opinión/El Heraldo survey of 800 adults nationwide with a 3.5% margin of error found that 95% of respondents have bought generic medicines.
• President Claudia Sheinbaum’s administration announced the liberation of 386 pharmaceutical patents for 2025 to broaden market choices and drive down drug costs.
• CANIFARMA and COFEPRIS maintain that generics must pass strict bioequivalence tests, allowing no more than 20% variation from reference products to ensure therapeutic equivalence.
• Generic medicines typically sell for 70 to 85% less than branded drugs, making them a key factor in improving affordability and access.
• Industry and health authorities warn consumers to purchase generics only at pharmacies authorized by COFEPRIS to prevent exposure to falsified or substandard products.